adults with the same age and gender distribution as GLP-1 users, who consider themselves overweight and are not currently using a GLP-1 medication) to go out to eat to socialize specifically, suggesting that users of the medication see the experience as one that isnt just about the food
GLP-1 RA should be considered in all when no contraindications are present before initiation of insulin therapy, as they allow lower glycaemic targets to be reached with a lower injection burden and lower risk of hypoglycaemia and weight gain than with insulin alone
FDA-approved under brand names such as Zepbound and Mounjaro, tirzepatide has demonstrated weight loss exceeding 20% in some clinical studies
How To Use: Take 2 soft gels 1 to 3 times daily with meals
All five long-acting GLP-1RAs can reduce glucose levels and BW [4, 22, 23, 26, 27]